PATRONI, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 960
EU - Europa 459
AS - Asia 310
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 1
Totale 1.733
Nazione #
US - Stati Uniti d'America 957
CN - Cina 218
UA - Ucraina 178
DE - Germania 82
IT - Italia 61
FI - Finlandia 55
HK - Hong Kong 48
IE - Irlanda 27
IN - India 22
GB - Regno Unito 17
FR - Francia 16
SG - Singapore 13
BE - Belgio 10
SE - Svezia 10
IR - Iran 5
CA - Canada 3
EU - Europa 3
TR - Turchia 3
BD - Bangladesh 1
BR - Brasile 1
ES - Italia 1
HU - Ungheria 1
NL - Olanda 1
Totale 1.733
Città #
Jacksonville 128
Woodbridge 95
Fairfield 87
Chandler 75
Wilmington 66
Ann Arbor 61
Ashburn 55
Nanjing 54
Princeton 53
Beijing 48
Hong Kong 48
Cambridge 45
Houston 45
Seattle 43
Helsinki 30
Dublin 27
New York 18
Jinan 14
Nanchang 14
Changsha 13
Hebei 12
Shenyang 12
Des Moines 11
Brussels 10
Tianjin 8
Dearborn 7
San Diego 7
Shanghai 7
Hangzhou 6
Jiaxing 6
Ardabil 5
Brescia 5
Lanzhou 5
Milan 5
Los Angeles 4
Rome 4
Boardman 3
Guangzhou 3
Leawood 3
London 3
Norwalk 3
San Francisco 3
Taizhou 3
Toronto 3
Verona 3
Calolziocorte 2
Changchun 2
Kocaeli 2
Kunming 2
Ningbo 2
Redmond 2
Rimini 2
Zhengzhou 2
Augusta 1
Chicago 1
Dhaka 1
Haikou 1
Hanover 1
Lancaster 1
Monza 1
Nagold 1
Napoli 1
Paris 1
Pune 1
São Paulo 1
Taiyuan 1
Totale 1.189
Nome #
Prediction of early and confirmed virological response by genotypic inhibitory quotients for lopinavir in patients naive for lopinavir with limited exposure to previous protease inhibitors. 117
HIV susceptibility to amprenavir: phenotype-based versus rules-based interpretations 100
Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy. 98
Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients. 97
Immune correlates of virological response in HIV-positive patients after highly active antiretroviral therapy (HAART) 94
HIV-1 resistance to dideoxynucleoside reverse transcriptase inhibitors: genotypic-phenotypic correlations 92
Long-term immunological benefit in patients with discordant responses to therapy depends on both level of viremia and duration of rebound 86
Why not to use colchicine in COVID-19? An oldanti-inflammatory drug for a novel auto-inflammatory disease 68
Hepatitis viruses coinfections, antiretrovirals hepatotoxicity and risk of death in HIV infected patients: a prospective cohort study 64
Aspetti epidemiologico-clinici della malattia da HIV in immigrati da Paesi in via di sviluppo 64
Co-infezione HIV-HCV e dislipidemie in corso di Highly Active Antiretroviral Therapy (HAART) 63
Immigrazione ed infezione da HIV: Profilo clinico-epidemiologico in una casistica di immigrati a Brescia 62
Lopinavir plasma levels in salvage regimens by a population of highly active antiretroviral therapy-treated HIV-1-positive patients. 60
Conoscenze, attitudini e pratiche in tema di allattamento delle donne gravide in Africa Sub-Sahariana. Uno studio collaborativi in aree di elevata prevalenza. 59
Immunologic benefit correlates with long-term clinical outcome in discordant responders to therapy 56
Clinical and epidemiological aspects of HIV infection among migrants in northern Italy 54
Co-infezione HIV-HCV e dislipidemie in corso di terapia antiretrovirale ad elevata efficacia (HAART) 54
Profilo clinico-epidemiologico dell'infezione da HIV in una casistica di immigrati a Brescia 54
La risposta viro-immunologica discordante nella pratica clinica 54
AIDS/HIV – Epidemiologia Internazionale 52
Evidence of HIV-2 Infection in Northern Italy 51
Hepatotoxicity associated with non nucleoside reverse trasciptase inhibitors (NNRTI) in 427 adults infected with Human Immunodeficiency Virus. 51
I Data-Base clinici e la sorveglianza degli eventi avversi alla HAART: il Progetto MASTER 51
Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy 49
Profilo clinico-epidemiologico dell'infezione da HIV in una casistica di immigrati a Brescia 42
Predictors of mortality in hospitalised HIV-infected patients in resource-limited setting. 41
Multicentric electronic-based surveillance of treatment-limiting adverse events under HAART in the clinical setting. The italian MASTER clinical data base 37
Outcome immunologico a 24 mesi dei pazienti HIV positivi con risposta discordante alla HAART 1
Totale 1.771
Categoria #
all - tutte 7.123
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.123


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201956 0 0 0 0 0 0 0 0 0 0 28 28
2019/2020449 78 7 10 50 14 45 34 43 30 102 5 31
2020/2021323 1 33 5 46 4 46 8 36 62 38 36 8
2021/2022213 4 30 2 5 1 17 4 11 11 39 25 64
2022/2023229 29 5 4 11 21 67 0 22 42 1 11 16
2023/2024162 15 8 11 27 5 25 13 7 49 2 0 0
Totale 1.771